Panbela Therapeutics, Inc.
PBLA
Revenue
36.80k
▼-15.00k▼-28.96%
3 Months ChangeAssets
9.41M
▼-1.11M▼-10.57%
3 Months ChangeLiabilities
19.98M
▲6.27M▲45.72%
3 Months ChangeFree Cash Flow
-8.68k
▼-8.68k-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0001437749-24-032318
2024-09-27
Form 8-K
ID: 0001437749-24-030192
2024-08-13
Form 10-Q
ID: 0001437749-24-026462
2024-08-13
Form 8-K
ID: 0001437749-24-026387
2024-07-30
Form 8-K
ID: 0001437749-24-023926
2024-07-03
Form 8-K
ID: 0001437749-24-022192
2024-05-29
Form 8-K
ID: 0001437749-24-018539
2024-05-15
Form 10-Q
ID: 0001437749-24-017064
2024-05-15
Form 8-K
ID: 0001437749-24-017059
2024-04-25
Form 8-K
ID: 0001437749-24-013250